PubMed:32552110 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/32552110","sourcedb":"PubMed","sourceid":"32552110","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/32552110","text":"Perspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India.\nPURPOSE: The coronavirus disease 2019 (COVID-19) pandemic has imposed a unique challenge to oncology patients and their treatment. There is no study related to the patients' preference for systemic therapy during this pandemic. We have conducted a prospective study to analyze that aspect.\nMETHODS: All consecutive patients who visited during the lockdown period from April 1-10, 2020, for systemic chemotherapy were included in the study for a questionnaire-based survey to evaluate the willingness to continue chemotherapy during this pandemic and factors influencing the decisions.\nRESULTS: A total of 302 patients were included (median age, 56 years; range, 21-77 years). Most common sites of cancer were breast (n = 114), lung (n = 44), ovary (n = 34), and colon (n = 20). Home address was within the city for 125 patients (42%), outside the city for 138 (46%), and outside the state for 37 (12%). Treatment was curative in 150 patients and palliative in 152. Educational status was primary and above for 231 patients and no formal schooling for 71. A total of 203 patients wanted to continue chemotherapy, 40 wanted to defer, and 56 wanted the physician to decide. Knowledge about COVID-19 strongly correlated with intent of treatment (P = .01), disease status (P = .02), knowledge about immunosuppression (P \u003c .001), home location (P = .02), and education status (P = .003). The worry about catching SARS-CoV-2 was high in those with controlled disease (P = .06) and knowledge about immunosuppression (P = .02). Worry about disease progression was more with palliative intent (P \u003c .001).\nCONCLUSION: This study shows that oncology patients in our country are more worried about disease progression than the SARS-CoV-2 and wish to continue chemotherapy during this pandemic. The treatment guidelines in the COVID-19 scenario should incorporate patients' perspectives.","tracks":[{"project":"LitCovid-OGER-BB","denotations":[{"id":"T1","span":{"begin":40,"end":48},"obj":"SP_7"},{"id":"T2","span":{"begin":118,"end":129},"obj":"NCBITaxon:11118"},{"id":"T3","span":{"begin":144,"end":152},"obj":"SP_7"},{"id":"T4","span":{"begin":814,"end":820},"obj":"UBERON:0000310"},{"id":"T5","span":{"begin":832,"end":836},"obj":"UBERON:0002048"},{"id":"T6","span":{"begin":847,"end":852},"obj":"UBERON:0000992"},{"id":"T7","span":{"begin":867,"end":872},"obj":"UBERON:0001155"},{"id":"T8","span":{"begin":1292,"end":1300},"obj":"SP_7"},{"id":"T9","span":{"begin":1399,"end":1416},"obj":"CHEBI:35705"},{"id":"T10","span":{"begin":1399,"end":1416},"obj":"CHEBI:35705"},{"id":"T11","span":{"begin":1512,"end":1522},"obj":"SP_7"},{"id":"T12","span":{"begin":1595,"end":1612},"obj":"CHEBI:35705"},{"id":"T13","span":{"begin":1595,"end":1612},"obj":"CHEBI:35705"},{"id":"T14","span":{"begin":1819,"end":1829},"obj":"SP_7"},{"id":"T15","span":{"begin":1918,"end":1926},"obj":"SP_7"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"attributes":[{"subj":"T1","pred":"source","obj":"LitCovid-OGER-BB"},{"subj":"T2","pred":"source","obj":"LitCovid-OGER-BB"},{"subj":"T3","pred":"source","obj":"LitCovid-OGER-BB"},{"subj":"T4","pred":"source","obj":"LitCovid-OGER-BB"},{"subj":"T5","pred":"source","obj":"LitCovid-OGER-BB"},{"subj":"T6","pred":"source","obj":"LitCovid-OGER-BB"},{"subj":"T7","pred":"source","obj":"LitCovid-OGER-BB"},{"subj":"T8","pred":"source","obj":"LitCovid-OGER-BB"},{"subj":"T9","pred":"source","obj":"LitCovid-OGER-BB"},{"subj":"T10","pred":"source","obj":"LitCovid-OGER-BB"},{"subj":"T11","pred":"source","obj":"LitCovid-OGER-BB"},{"subj":"T12","pred":"source","obj":"LitCovid-OGER-BB"},{"subj":"T13","pred":"source","obj":"LitCovid-OGER-BB"},{"subj":"T14","pred":"source","obj":"LitCovid-OGER-BB"},{"subj":"T15","pred":"source","obj":"LitCovid-OGER-BB"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-OGER-BB","color":"#93ece0","default":true}]}]}}